|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/24 |
| (11) | Patento numeris | 2064246 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08714214.7 |
| Europos patento paraiškos padavimo data | 2008-02-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-06-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-05-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/001717 |
| Data | 2008-02-08 |
| (87) | Numeris | WO 2008/153610 |
| Data | 2008-12-18 |
| (30) | Numeris | Data | Šalis |
| 889475 P | 2007-02-12 | US |
| (72) |
KOPF, Manfred, CH
ROMANI, Luigina, IT
KASTELEIN, Robert, A., US
CHACKERIAN, Alissa, A., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | USE OF IL-23 ANTAGONISTS FOR TREATMENT OF INFECTION |
| USE OF IL-23 ANTAGONISTS FOR TREATMENT OF INFECTION |